Results 201 to 210 of about 16,818,363 (252)

Mental health outcomes and psychosocial correlates among adult members of business families in Germany (WIFU-GESUND): study protocol for a representative cross-sectional study. [PDF]

BMJ Open
Kitta P, Wendt M, Josupeit J, Kleve H, Rüsen T, Hunger-Schoppe C.   +5 more
europepmc   +1 more source

EJBO. Electronic journal of business and organization ethics, 2008 VOLUME 13, NUMBER 2 (The Entire Issue)

, 2008
Business and Organization Ethics Network (BON)
core  

The future of scholarly blogs: Scholarly bloggers' perspectives on long‐term preservation

Journal of the Association for Information Science and Technology, EarlyView.
Abstract Scholarly blogs are an important venue for scholarly communication; however, they are not yet integrated into the preservation workflows of digital research and information infrastructures, which places their long‐term access at risk. By using Star and Ruhleder's (1996) dimensions of information infrastructure as a theoretical framework, in ...
Catharina Ochsner, Heinz Pampel
wiley   +1 more source

The academic research organization model in universityindustry collaboration: Policy evolution and institutional reform in Japan's university hospitals. [PDF]

GHM Open
Yoshimura K, Suzuka R, Sakurai Y.
europepmc   +1 more source

Early‐stage health technology assessment of a curative gene therapy for multiple sclerosis

British Journal of Clinical Pharmacology, EarlyView.
Aims Multiple sclerosis (MS) is associated with significant early morbidity, reduced life expectancy and substantial healthcare and societal costs. The primary objective of this study is to assess the early cost‐effectiveness potential of a novel gene therapy, IMMUTOL, for MS compared with current high‐efficacy treatment sequences.
Attila Imre, Balázs Nagy, Rok Hren
wiley   +1 more source

The ethics-driven data governance framework for health-based AI (EDG-AI4H): an integrated approach for empowering explainable AI in health insurance risk prediction in Iran. [PDF]

Dialogues Health
Rahimi R.
europepmc   +1 more source

Beyond the label: Rethinking off‐label drug use in paediatrics. Towards a scientifically grounded and safer future for paediatric pharmacotherapy

British Journal of Clinical Pharmacology, EarlyView.
Abstract Despite regulatory progress being made in the past two decades, off‐label drug use in paediatrics remains pervasive, with prevalence estimated between 3% and 97% of prescriptions across different clinical settings. Off‐label use—defined as prescribing outside the conditions described in the Summary of Product Characteristics (SmPC)—is often ...
Tjitske M. van der Zanden, Miriam G. Mooij, Matthijs de Hoog, Saskia N. de Wildt   +3 more
wiley   +1 more source

Through the lens of marketing authorization holders: experience in use of real‐world data and real‐world evidence in drug development and regulatory submissions in EU

British Journal of Clinical Pharmacology, EarlyView.
Abstract Aim The aim of this study was to assess the general and product‐specific experiences of MAHs use of RWD/RWE in medicines development and in their regulatory submissions, and to explore organizational aspects of MAHs related to RWD/RWE. Methods An electronic survey was conducted, and information collected directly from MAHs.
Sini M. Eskola, Aleksandar Gigov, Hubertus G. M. Leufkens, Andrew Bate, Marie Louise De Bruin, Helga Gardarsdottir   +5 more
wiley   +1 more source

EJBO. Electronic journal of business and organization ethics, 2005 VOLUME 1, NUMBER 2 (The Entire Issue)

, 2005
Business and Organization Ethics Network (BON)
core